Literature DB >> 1547423

Acceptability of opportunistic screening for occult gastrointestinal blood loss.

F D Hobbs1, R C Cherry, J W Fielding, L Pike, R Holder.   

Abstract

OBJECTIVE: To test patient compliance for faecal occult blood testing in suburban and inner city general practice.
DESIGN: Prospective opportunistic trial using the Haemoccult test kit. Tests were offered during routine surgery attendance.
SETTING: Three group general practices in Birmingham.
SUBJECTS: All patients aged 40 years or older on the start date who routinely attended surgery during two years. MAIN OUTCOME MEASURES: Numbers of patients approached for testing and the numbers refusing, accepting, and returning the test kits.
RESULTS: Only 26.3% (1230/4677) of the potential target population had been screened within the two years, although 988 (39.3%) of the suburban practice target were screened. However, 55.7% (1230/2207) of patients actually offered a test returned completed kits, with only 6% (133) refusing the kit. 683 (61.6%) patients aged 50-69 returned kits, compared with 343 (54.3%) aged 70 or over and 204 (43.8%) aged 40-49. These differences were significant (p less than 0.001). Patients from the inner city practice were significantly less likely to be offered the test than those in suburban practice (242 (11.2%) v 988 (39.9%), p less than 0.001) and return the samples (242 (38.8%) v 988 (62.4%), p less than 0.001). Patients from the inner city practice were also more likely to refuse the test (78 (12.5%) v 55 (3.5%), p less than 0.001).
CONCLUSIONS: Opportunistic testing for occult faecal blood in asymptomatic patients was reasonably acceptable to patients, especially those in a suburban practice. If the test is shown to reduce mortality from colorectal cancer then formal screening would probably achieve acceptable target rates, especially among patients aged 50-69, who represent the prime risk group.

Entities:  

Mesh:

Year:  1992        PMID: 1547423      PMCID: PMC1881104          DOI: 10.1136/bmj.304.6825.483

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  19 in total

1.  Health checks for adults.

Authors:  G Fowler; D Mant
Journal:  BMJ       Date:  1990-05-19

2.  Haemoccult compliance rates and reasons for non-compliance.

Authors:  V Box; S Nichols; R C Lallemand; P Pearson; P A Vakil
Journal:  Public Health       Date:  1984-01       Impact factor: 2.427

3.  The survival of patients with colorectal cancer treated in a regional hospital.

Authors:  P G Gill; P J Morris
Journal:  Br J Surg       Date:  1978-01       Impact factor: 6.939

4.  Prospective randomised controlled trial of methods of call and recall for cervical cytology screening.

Authors:  M Pierce; S Lundy; A Palanisamy; S Winning; J King
Journal:  BMJ       Date:  1989-07-15

5.  Experiences of patients with false positive results from colorectal cancer screening.

Authors:  D Mant; R Fitzpatrick; A Hogg; A Fuller; A Farmer; J Verne; J Northover
Journal:  Br J Gen Pract       Date:  1990-10       Impact factor: 5.386

6.  Can health screening damage your health?

Authors:  H G Stoate
Journal:  J R Coll Gen Pract       Date:  1989-05

7.  Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects.

Authors:  J D Hardcastle; W M Thomas; J Chamberlain; G Pye; J Sheffield; P D James; T W Balfour; S S Amar; N C Armitage; S M Moss
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

8.  Promoting prevention in primary care: controlled trial of low technology, low cost approach.

Authors:  E Fullard; G Fowler; M Gray
Journal:  Br Med J (Clin Res Ed)       Date:  1987-04-25

9.  Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas.

Authors:  F A Macrae; D J St John
Journal:  Gastroenterology       Date:  1982-05       Impact factor: 22.682

10.  Delay in diagnosis and treatment of symptomatic colorectal cancer.

Authors:  H W Holliday; J D Hardcastle
Journal:  Lancet       Date:  1979-02-10       Impact factor: 79.321

View more
  11 in total

1.  The health of the nation from a local perspective.

Authors:  D Cox
Journal:  Br J Gen Pract       Date:  1992-05       Impact factor: 5.386

2.  Screening for colorectal cancer.

Authors:  A Anand; N Anand; A Anand
Journal:  Gut       Date:  1996-09       Impact factor: 23.059

3.  The effect on compliance of a health education leaflet in colorectal cancer screening in general practice in central England.

Authors:  A R Hart; T L Barone; S P Gay; A Inglis; L Griffin; C A Tallon; J F Mayberry
Journal:  J Epidemiol Community Health       Date:  1997-04       Impact factor: 3.710

4.  Colorectal cancer prevention. An approach to increasing compliance in a faecal occult blood test screening programme.

Authors:  A R Hart; J Eaden; S Barnett; A M de Bono; J F Mayberry
Journal:  J Epidemiol Community Health       Date:  1998-12       Impact factor: 3.710

5.  Screening for colorectal cancer: a general-practice-based study.

Authors:  J Marjoram; R Strachan; A Allan; E Allan
Journal:  Br J Gen Pract       Date:  1996-05       Impact factor: 5.386

6.  Screening for colorectal cancer: reasons for refusal of faecal occult blood testing in a general practice in England.

Authors:  K A Hynam; A R Hart; S P Gay; A Inglis; A C Wicks; J F Mayberry
Journal:  J Epidemiol Community Health       Date:  1995-02       Impact factor: 3.710

7.  An industry based approach to colorectal cancer screening in an asymptomatic population.

Authors:  A R Hart; N Glover; J Howick-Baker; J F Mayberry
Journal:  Postgrad Med J       Date:  2003-11       Impact factor: 2.401

8.  Screening for colorectal cancer.

Authors:  J Austoker
Journal:  BMJ       Date:  1994-08-06

9.  Colorectal cancer screening in asymptomatic populations.

Authors:  A R Hart; A C Wicks; J F Mayberry
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

10.  Factors affecting attitudes toward colorectal cancer screening in the primary care population.

Authors:  T Taskila; S Wilson; S Damery; A Roalfe; V Redman; T Ismail; R Hobbs
Journal:  Br J Cancer       Date:  2009-06-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.